ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      64,002.00
      1.77%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Fennec Pharmaceuticals Inc (FENC)

      7. Fennec Pharmaceuticals Inc (FENC) News

      FENC

      Fennec Pharmaceuticals (FENC)

      Fennec Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FENC
      DateTimeSourceHeadlineSymbolCompany
      03/21/20246:00AMGlobeNewswire Inc.Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
      03/19/20246:01AMGlobeNewswire Inc.Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
      03/18/20243:00AMPR Newswire (US)Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
      03/17/20249:00PMGlobeNewswire Inc.Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
      03/06/20244:07PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FENCFennec Pharmaceuticals Inc
      02/29/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FENCFennec Pharmaceuticals Inc
      02/29/20247:04AMGlobeNewswire Inc.Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsNASDAQ:FENCFennec Pharmaceuticals Inc
      02/14/202410:47AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FENCFennec Pharmaceuticals Inc
      02/01/20245:55AMGlobeNewswire Inc.FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving CisplatinNASDAQ:FENCFennec Pharmaceuticals Inc
      01/05/20245:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      01/05/20244:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      01/04/20244:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      12/29/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      12/28/20233:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      12/18/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FENCFennec Pharmaceuticals Inc
      12/05/20235:55AMGlobeNewswire Inc.Fennec Announces Incremental $5 Million Investment from PetrichorNASDAQ:FENCFennec Pharmaceuticals Inc
      11/16/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      11/09/20234:56PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FENCFennec Pharmaceuticals Inc
      11/09/20234:52PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
      11/09/20234:50PMGlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
      11/09/20234:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      11/08/20236:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      11/06/20235:59AMGlobeNewswire Inc.Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
      11/03/20235:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      10/30/20236:45AMGlobeNewswire Inc.Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:FENCFennec Pharmaceuticals Inc
      09/07/20235:59AMGlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
      08/07/20235:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
      08/07/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
      08/07/202310:51AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FENCFennec Pharmaceuticals Inc
      08/04/202310:58AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FENCFennec Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:FENC